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Background: The development of developmental dysplasia of the hip can be attributed to several risk factors and
often in combination with each other. When predicting the likelihood of developing this condition, clinicians tend
to over and underestimate its likelihood of occurring.
Therefore, the study aim is to determine among at-risk newborns how to best predict developmental dysplasia of
the hip (DDH) within 8 weeks post-partum.
Methods: Prospective cohort study in secondary care. Patient population included newborns at-risk for DDH – we
assessed 13,276 consecutive newborns for the presence of DDH risk factors. Only newborns with at least one of the
predefined risk factors and those showing an abnormal examination of the hip were enrolled (n = 2191). For the
development of a risk prediction model we considered 9 candidate predictors and other variables readily available
at childbirth.
The main outcome measure was ultrasonography at a median age of 8 weeks using consensus diagnostic criteria;
outcome assessors were blinded.
Results: The risk model includes four predictors: female sex (OR = 5.6; 95% CI: 2.9–10.9; P < 0.001); first degree
family history of DDH (OR = 4.5; 95% CI: 2.3–9.0; P < 0.001), birthweight > 4000 g (OR = 1.6; 95% CI: 0.6–4.2; P = 0.34),
and abnormal examination of hip (OR = 58.8; 95% CI: 31.9, 108.5; P < 0.001). This model demonstrated excellent
discrimination (C statistic = 0.9) and calibration of observed and predicted risk (P = 0.35). A model without the
variable ‘hip examination’ demonstrated similar performance.
Conclusion: The risk model quantifies absolute risk of DDH within 8 weeks postpartum in at-risk newborns. Based
on clinical variables readily available at the point of childbirth, the model will enhance parental counselling and
could serve as the basis for real time decisions prior to discharge from maternity wards.
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In early infancy the spectrum of developmental dysplasia
of the hip (DDH) represents a continuum of risk from
benign self-limiting instability to frank dislocation that
requires rapid orthopaedic input. Multiple widely ac-
cepted perinatal risk factors are used to identify at-risk
newborns and triage them to, for example, rapid ortho-
paedics referral or selective ultrasound screening. New-
borns and infants with the following features are
generally thought to be at-risk for DDH: female sex,
family history of DDH, breech delivery, first born, and
abnormal examination of the hip [1]. Less widely ac-
cepted factors include foot deformities, [2, 3] high birth
weight, [4] and torticollis [5].
With use of these factors clinicians on maternity wards
estimate the likelihood of DDH to be present or to de-
velop; counsel parents of affected newborns; and make
triage decisions. However, the risk factors often tend to
occur in combinations and since they are interrelated,
clinicians could over or underestimate the likelihood of
DDH being present or becoming present. A risk model
that could help clinicians making predictions about
DDH for individual at-risk newborns would thus be a
useful tool for clinicians.
The aim of our study was to develop a new prediction
model that can generate absolute predicted risk of DDH
within 8 weeks postpartum on the basis of each at-risk
newborn’s individualised clinical risk profile.
Methods
Setting and eligibility
Consecutive newborns of an urban teaching hospital in
London, England, and those referred by family physi-
cians were eligible for this prospective cohort study, con-
ducted from November 2010 to January 2013. This
hospital provides ante and postnatal services for the
local population and acts as a tertiary referral unit for
pregnant women and neonates. The local population is
mixed representing all socioeconomic groups in a multi
ethnic community. Newborns were ineligible if they had
a syndrome or neurological disorder, which by definition
excludes DDH as a possible diagnosis. The Institutional
Review Board approved the study. Caregivers provided
written informed consent.
Predictor selection and measurement
A dedicated research team examined each newborn and
community referral and ascertained all variables pro-
spectively. The median newborn age at this assessment
was 1 day (interquartile range, 0–1 days). We assessed
newborns for the presence of widely-accepted DDH risk
factors, based on systematic reviews, [1, 5, 6] clinical
guidelines, [7] and a consensus document of experts
from 34 countries [8]. These included a family history ofDDH in a first degree relative (parental self-report);
breech lie in the third trimester with cephalic presenta-
tion or breech presentation at birth; and history of oligo-
hydramnios (ultrasound-based diagnosis at 18th to 20th
week of gestation with amniotic fluid index ≤5). We also
recorded sex, birth weight; whether it was a first born
child; a twin pregnancy; a vaginal or a caesarean
delivery.
All newborns underwent an examination of their hips
and we ascertained the presence of standardized diag-
nostic criteria for DDH [8] – Ortolani or Barlow sign;
asymmetry in hip abduction ≥20°; leg length discrepancy
(Galeazzi sign). We recorded the presence of a torticol-
lis. We included all foot deformity and grouped them
(based on the assessment of a physiotherapist) into those
with marked postural deformities (e.g. metatarsus adduc-
tus; calcaneovalgus) that we followed on at least one oc-
casion with a physiotherapist to ensure improvement;
and those with clubfeet that we immediately referred to
a surgeon). Neonatology residents, overseen by attending
neonatologists and dedicated research nurses, carried
out these assessments. Newborns with abnormal or
equivocal clinical examination of the hip underwent a
concurrent examination by an attending neonatologist
or attending pediatric orthopaedics surgeon to confirm
eligibility. During the course of the study 68 infants were
referred by family physicians for a possible diagnosis of
DDH due to risk factors and we included them all. Cen-
tral project staff ensured quality through training ses-
sions and regular on-site data quality audits. We
ensured recruitment of consecutive patients by daily
comparing the number of newborns with the number of
case report forms completed (birth occurring on week-
ends were compared on Mondays). The same was done
weekly for referrals made by family physicians. We ran-
domly performed double examination of 230 hips (115
infants) to determine the inter-rater reliability in the hip
examination between the team of residents and a
pediatric orthopaedics surgeon: hips were examined reli-
ably (inter-rater κ = 0.90).
Outcome
One outcome was assessed for all patients – ultrasound-
based diagnosis of DDH at age 6–8 weeks (median, 8
weeks). We classified sonograms with use of standard-
ized diagnostic criteria based on international consensus
[8] which define an α-angle [9] < 55° as DDH. This out-
come is robust as any such finding warrants monitoring
or treatment [8]. In rare instances where hips were
scanned before 6 weeks because of suspected dislocation,
we defined α < 43° as DDH [8].
Two senior attending pediatric radiologists and 3
sonographers specifically trained in infant hip ultrason-
ography performed (and reported) all ultrasound tests in
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[9] (GE Medical Systems, Chalfont St. Giles, United
Kingdom). We (AR, PH) evaluated all scans that had
been reported as α < 60°, blinded to predictors and ori-
ginal report; we performed our own measurement of the
α-angle, which we used for this study. We did the same
for a random sample of scans that had been reported as
α > 60°; we found that our measurements were consist-
ent with the initial report in all cases and thus assumed
robustness of the initial report. Inter-rater reliability
studies for the α-angles in the original scan reports and
that reported by the study team showed an intra-class
correlation coefficient of 0.88 (95% confidence interval,
0.86–0.90).
Of 13,208 livebirths and 68 community referrals, 2276
(17%) newborns were eligible (Fig. 1). Of those, 80 (3%)
caregivers declined participation. Of 2191 consented
newborns, 1953 (89%) completed the ultrasound and
were included in the analysis; 238 (11%) infants who did
not were excluded (Table 1).
Statistical analysis
We summarized all variables as means and standard de-
viations or frequencies and proportions, respectively. We
treated the occurrence of DDH as a binary outcome
(based on α < 55° at age > 42 days, or α < 50 at age < 42Fig. 1 Flowchart showing patient eligibility and enrollmentdays). We considered for inclusion in the risk prediction
model only candidate predictors with a prevalence of >
2% in order to avoid imprecise estimates of regression
coefficients [10]. We combined less frequently occurring
predictors if clinically plausible (e.g. we created the vari-
able abnormal hip examination, encompassing any hips
showing any of the following: positive Barlow, Ortolani,
or Galeazzi signs, or asymmetry in abduction ≥20° - hips
exhibiting multiple of these criteria were counted once
only). We also combined all foot deformities warranting
followup with a physiotherapist or with a surgeon into
one variable, ‘foot deformity’. The variables oligohy-
dramnios and torticollis were omitted from analysis due
to their low prevalence. This resulted in 9 candidate pre-
dictors to be analyzed (Additional file 1).
Variables associated with DDH at p < 0.10 in simple
logistic regression were taken to multivariate analysis.
They were: female sex, family history of DDH, first born,
birth weight, foot deformity warranting followup, and
abnormal hip examination. Because “breech presenta-
tion/breech in last trimester” is a widely accepted risk
factor, we explored this variable further despite it not
meeting this threshold. We tested if the mode of delivery
(vaginal or caesarean) would affect its association with
DDH. No such effect was seen. Hence, we omitted
‘breech presentation/breech in last trimester’ from
Table 1 Baseline characteristics of 2271 eligible infants. Values are numbers (percentages) unless stated otherwise
Variable Enrolled
(N = 2191)
Declined participation
(N = 80)
Recruited from maternity ward 2123 (96.9) 76 (95)
Referred by family physician 68 (3.1) 4 (5)
Mean age at assessment in days (SD) 3.5 (14.8) 2.1 (5.6)
Lost to follow-up 220 (10) 4 (5)
Received treatment for DDH 76 (3.5) 3 (4)
Female-to-male ratio 1142:1049 44:36
Female sex 1142 (52.1) 44 (55)
First born child 1229 (56.1) unknown
One of twins (twin pregnancy) 285 (13) 6 (8)
Birth weight in grams (mean ± SD) 3220 ± 583 unknown
Oligohydramnios 50 (2.3) 2 (3)
Breech lie in last trimester or at presentation 1419 (64.8) 45 (56)
Breech presentation 640 (29.2) 18 (23)
Breech lie in last trimester with cephalic presentation 779 (35.6) 27 (34)
Vaginal delivery 1020 (46.6) unknown
Caesarean section 1131 (51.6) unknown
First degree family history of DDH 205 (9.4) 3 (4)
Torticollis 12 (0.5) 0 (0)
Foot deformity with orthopaedic follow-up 9 (0.4) 2 (3)
Foot deformity with physiotherapist follow-up 46 (2.1) 3 (4)
Leg length discrepancy (Galeazzi sign) 16 (0.7) 1 (1)
Asymmetry in hip abduction 39 (1.8) 1 (1)
Barlow positive 21 (1) 0 (1)
Ortolani positive 14 (0.6) 1 (1)
Hip instability 27 (1.2) 1 (1)
SD standard deviation
Roposch et al. BMC Musculoskeletal Disorders          (2020) 21:442 Page 4 of 8further analyses. We dichotomised the variable birth
weight (because it would be easier to use for clinicians)
based on an accepted threshold of 4000 g [4, 8].
For derivation of a risk prediction model, we included
all 6 candidate predictors in a multivariable logistic re-
gression model and used backward elimination and
retained predictors at the 5% significance level. Four of 6
predictors retained in the model: female sex; family his-
tory; birth weight > 4000 g; and abnormal hip examin-
ation. We also developed a model without the variable
‘abnormal hip examination’ as this may be of interest for
certain groups of clinicians.
Birthweight was missing for 61 cases and first born
was missing for 35 cases. We used multiple imputation
(assuming data were missing at random) to account for
this missing data when fitting the final multivariable
models. The imputation models included all risk factors
considered in the univariate analysis (which we assume
includes all predictors of missingness). We generated 20
data sets and ran logistic regression, using the wholedata set and implementing a bootstrap (200 samples) for
each imputed data set to correct for overfitting. Results
from analyses using 20 imputed datasets were compared
with those only including infants without missing data
and no differences were found. We derived the final
models by fitting a logistic regression model for all sig-
nificant predictors. Estimates were combined using
Rubin rules [11].
Outcome data was missing for 238 infants. Summaries
of risk factor data showed these cases were not different
to cases with available ultrasound information. Further-
more, we ran a sensitivity analysis assuming all these
238 cases did not have DDH and found that results of
univariate analyses were similar to those for 1953 cases;
hence we ran multivariable models for cases with avail-
able outcome data only.
We assessed the performance of the model in terms of
the C statistic (a value of 1.0 is perfect) and calibration.
The C statistic represents the probability that for any
randomly selected pair of newborns with and without
Table 3 Risk prediction model
Risk score from a logistic regression model to predict DDH in the first
eight weeks postpartum. Risk score = − 5.50 + 1.73female sex + 1.51first
degree family history + 4.07hip-related factors + 0.48infant birth weight >
4000 g. All variables are coded as binary (0 or 1 for absence or presence
of a risk factor), except for infant birth weight. The value − 5.50 is the
intercept, and other numbers are the estimated regression coefficients
for the predictors, which indicate their mutually adjusted relative
contribution to the outcome risk. The regression coefficients represent
the log odds ratio for a change of 1 unit in the corresponding predictor.
The predicted risk of DDH = 1/1 + e−riskscore.
Example 1—A newborn whose older sibling received splinting for DDH
has a birth weight of 4100 g. She showed no abnormalities on the
newborn physical examination, in particular her hips were stable and
showed symmetric range of motion. She has a predicted risk of 14% of
developing DDH within the first eight weeks of delivery. Interpretation: if
100 newborns with the same risk factors are followed, one will develop
DDH within eight weeks of birth.
Example 2—A newborn girl was examined on the second day post-
partum before discharge from the maternity unit. The left hip was
restricted in movement, in particular in abduction. It appeared that the
leg lengths were different. The child’s predicted DDH risk is 86% within
the first eight weeks of delivery. Interpretation: if 100 newborns with the
same risk factors are followed, ninety will develop DDH within eight
weeks of birth
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dicted risk. Calibration refers to how similar the model-
estimated likelihood of DDH was to the observed likeli-
hood of DDH (Hosmer–Lemeshow goodness-of-fit test
– a well-fitting model will result in p > 0.05).
We validated the model to correct measures of pre-
dictive performance for optimism by bootstrapping 200
samples of the derivation data. We repeated the model
development process in each bootstrap sample as out-
lined above in order to produce a model, we applied the
model to the same bootstrap sample to quantify appar-
ent performance, and we applied the model to the ori-
ginal dataset to test model performance (C statistic and
calibration) and optimism (difference in test perform-
ance and apparent performance). We then estimated the
overall optimism across all models.
Sample size — in planning the study, we anticipated to
evaluate 6–7 independent covariates with a high-enough
(> 2%) prevalence in our sample. Our study revealed 77
cases of DDH, which allows for 8 covariates to be exam-
ined in multivariable analysis [12].
The local research ethics board approved this study
(research ethics committee reference: 14/LO/0420).Table 2 Simple regression analysis of candidate predictors in 1953 infants who had outcomes ascertained (DDH was defined as α <
55° at age > 42 days, or α < 50 at age < 42 days). All values are numbers (percentages) unless otherwise stated
Candidate Predictor All
infants
(N = 1953)
Infants with DDH
(N = 77)
Odds ratio
(95% confidence interval)
P
Female sex 1037 (53.1) 65 (77) 5.04 (2.70, 9.39) < 0.001
First degree family history of DDH 184 (9.4) 15 (9) 2.44 (1.36, 4.39) 0.003
Vaginal delivery 892 (45.7) 42(58) 1.59 (0.99, 2.55) 0.06
Birth weight in kg (mean ± SD) 3.22 ± 0.58 3.40 ± 0.52 1.81 (1.14, 2.87) 0.01
Foot deformity warranting followup c 51 (2.6) 5 (8) 2.76 (1.07, 7.16) 0.04
First born child 1108 (56.7) 46 (66) 1.35 (0.82, 2.23) 0.24
Multiple birth (twin pregnancy) 257 (13.2) 6 (9) 0.61 (0.26, 1.41) 0.25
Breech at presentation 586 (30.0) 20 (39) 0.81 (0.48, 1.36) 0.43
Oligohydramnios 39 (2.0) 0 (0) NAa NAa
Torticollis 10 (0.5) 1 (1) NAb NAb
Abnormal hip examination d 86 (4.4) 43 (56) 53.91 (31.35, 92.71) < 0.001
Ortolani positive 14 (0.7) 11 (14) NAb NAb
Barlow positive 20 (1.0) 14 (18) NAb NAb
Galeazzi positive (leg length discrepancy) 16 (0.8) 11 (14) NAb NAb
Hip instability 25 (1.3) 7 (9) NAb NAb
Asymmetry in hip abduction 36 (1.8) 21 (27) NAb NAb
SD standard deviation
aNot possible to estimate because no DDH cases had oligohydramnios
bNot applicable (NA) for risk model due to low prevalence
cFoot deformity receiving orthopedic or physiotherapy follow-up
dThis variable includes hips with at least one of the following criteria present: leg length discrepancy, asymmetry of hip abduction, Barlow positive, Ortolani
positive, hip instability. The latter 3 were mutually exclusive. This variable thus indicates hips that showed an abnormal physical examination
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Of 9 candidate predictors examined, 6 were associated
(P < 0.1) with DDH in univariate analysis (Table 2). Of
these, we ultimately retained 4 in the risk prediction
model: female sex (OR = 5.6, 95% CI, 2.9–10.9; P <
0.001); family history of DDH (OR = 4.5, 95% CI, 2.3–
9.0; P < 0.001); birthweight > 4000 g (OR = 1.6, 95% CI,
0.6–4.2; P = 0.34); abnormal examination of hip (OR =
58.8, 95% CI, 31.9–108.5; P < 0.001) (Table 3). This
model discriminated well between newborns with and
without DDH (C statistic = 0.9, 95% CI, 0.8–0.9;
goodness-of-fit P = 0.35). Omitting 68 community refer-
rals from the analysis did not change these results.
A model omitting the variable ‘abnormal hip examin-
ation’ gave the following odds ratios: female sex 5.8 (95%
CI, 3.1–11.0; P < 0.001), family history of DDH 2.6 (95%
CI, 1.4–4.7; P < 0.001), birthweight > 4000 g 3.1 (95% CI,
1.6–6.0; P < 0.001). This model also discriminated be-
tween cases with and without DDH (C statistic 0.7, 95%
CI, 0.7–0.8; goodness-of-fit P = 0.76).
Discussion
Multiple widely-accepted risk factors obtained at bedside
are used to identify newborns at-risk for DDH. The
additive effects and the interrelationships of these risk
factors, however, remain ill-defined. Understanding how
to best harness the several risk factors in order to calcu-
late an individual newborn’s risk of being diagnosed with
DDH within 8 weeks of birth could be an important
addition to the counselling of mothers of at-risk infants,
and to the design of postnatal care pathways. We
present a new risk prediction model to calculate the ab-
solute risk of DDH in the first 8 weeks postpartum in a
large representative sample of at-risk newborns.
Model performance
Our prediction model demonstrated excellent discrimin-
ation, that is, the ability to predict correctly amongst at-
risk newborns those who have DDH. And it does so with
use of only 4 perinatal risk factors. To correct measures
of predictive performance for optimism, we did internal
validation by bootstrapping. The optimism-adjusted C
statistic was 0.9, with a lower bound of 0.8 in its 95%
confidence interval, indicating excellent discrimination.
We observed good agreement of DDH cases based on
our model’s prediction and the original data: only 2 of
77 (2.5%) newborns with DDH were not predicted by
our model.
Based on our model at-risk newborns have a 19% risk
of obtaining a diagnosis of DDH within 8 weeks if the
newborn hip examination is abnormal. This risk is mark-
edly lower for newborns who exhibit other single risk
factors, ranging from 0.4% for those with a birthweight
> 4000 g to 2% for those who are girls or those who havea positive family history. The model revealed the nature
of the additive effect of risk factors – the risk is 50% if
an abnormal hip exam is found in newborns with a fam-
ily history of DDH; or 67% if found in girls. A very high
risk of 86% occurs in girls who have an abnormal hip
exam as well as a positive family history (Table 3).
Model content
The strongest single predictor was an abnormal physical
examination of the hip – 43 of 86 (50%) infants with an
abnormal examination of the hip had DDH confirmed.
An abnormal examination of the hip is not always a def-
inite symptom of DDH since hips can improve spontan-
eously in this age group. However, the second model
that we present omits the hip examination entirely and
it performed comparably well in predicting cases with
and without DDH. We also encountered 34 cases of
DDH who exhibited a normal examination of the hip
and our model is particularly useful for this group.
Whilst we expected the variable ‘breech during last tri-
mester/breech delivery’ to be part of the risk prediction
model, it was not. Its odds ratio was 1.1 in an analysis
adjusted for the mode of delivery, with a 95% confidence
interval from 0.58 to 2.07 [13]. However, the reported
association between breech delivery and DDH varies
widely, with risk ratios for comparable age groups ran-
ging from ≥8.0 [4, 14] to 1.1 [15, 16] to no association
[17, 18]. Perhaps the sub-type ‘extended breech’ would
have shown statistical significance but since we did not
measured this detail this remains speculative. Whether a
foot deformity is a risk factor for DDH remains contro-
versial [2, 19] and our study was not designed to clarify
this issue. The definition of foot deformities in newborns
can be subjective, [14] with the potential for measure-
ment bias. We thus regarded only foot deformities that
required orthopaedics or physiotherapy followup (these
were severe metatarsus adductus and clubfeet) for the
analysis. In line with previous research, [19] having a
foot deformity was not associated with DDH in our
study.
The ascertainment of the variable ‘physical examin-
ation’ was of particular importance. Because we wanted
to create a risk prediction tool for use by maternity ward
doctors, we deliberately had neonatology residents
examine the hips of study participants. Although ortho-
paedics surgeons or neonatologists may generally be bet-
ter skilled in this task, they are typically not the ones
who carry out this task in daily clinical care. In order to
ensure robust collection of this information, we con-
ducted double-examinations of all newborns whose hips
were deemed to be abnormal by the residents. Further,
throughout the study period, paediatric orthopaedics
surgeons periodically trained all residents in the clinical
examination of the newborn hip. Whilst it is not
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findings still went unnoticed, our model performance re-
flects the average skills of those who are conducting the
postnatal examinations, which strengthens its
generalizability.
Strengths and limitations
We developed our prediction model with a high degree
of precision. In assembling the cohort, we defined ‘at-
risk’ with use of widely-accepted perinatal risk factors
based on a metaanalysis [1], an international Delphi con-
sensus study [8], and a population-based cohort study
[4]. We defined DDH by means of diagnostic criteria
based on the consensus of international experts [8]. We
measured outcome and predictors with great rigor using
double examinations, consensus readings, and blinding
where possible. We enrolled consecutive newborns and
observed high accrual.
We note the limitations of this study. First, the vari-
ables ‘torticollis’ and ‘oligohydramnios’ were not encoun-
tered frequently enough allow for statistical analysis.
Larger studies are needed to clarify if these two variables
improve the predictive performance of the model. Sec-
ond, the mothers of 3.5% of eligible newborns declined
participation. However, there is no evidence of sampling
bias; enrolled newborns were largely similar in their risk
factors as those enrolled (Table 1). Third, the outcome
was not ascertained by the study team in 238 (11%) of
enrolled cases. Of these, 24 had it ascertained elsewhere
with 2 cases of DDH confirmed; and 76 never had an
ultrasound scan done at all. It remains unknown what
happened to further 144 enrolled cases. We explored the
distribution of predictors in those with and without
ultrasound outcomes and they were similar. We then
did a sensitivity analysis of 2191 participants whereby we
assumed all the unknown outcomes to be non-DDH; the
results were similar to the analysis of 1953 participants
who had the ultrasound done by the study team.
Conclusions
Our prediction model can be used to express the abso-
lute predicted risk of DDH within 8 weeks postpartum
for an individual at-risk newborn. The model is based
on clinical variables available at the point of childbirth.
For newborns with one or more risk factors for DDH,
our model enables clinicians to refine the risks associ-
ated with each combination of risk factors. This infor-
mation could enhance the counselling of caregivers. It
could also be used to refine existing care pathways for
at-risk newborns in terms of ‘levels of urgency’ for in the
postnatal period. For example, those with risks > 80%
could be booked directly and before discharge from ma-
ternity wards for a two-week orthopaedics surgeon con-
sultation, and those with lower risks could be givenultrasound appointments at 6 weeks, etc. Naturally, such
decision will need to be based on local resources and are
beyond the scope of this study.
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Additional file 1. Flowchart showing the development of the risk
prediction model. We considered to include “breech presentation” in the
model – despite it was not significant in univariate analysis – and tested
the effect of breech in a model adjusted for mode of delivery. This effect
was not significant (OR=1.10, p = 0.76) and we omitted breech from
further analysis.
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DDH: Developmental dysplasia of the hip
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